{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ciclesonide&page=2", "query": { "intervention": "ciclesonide", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ciclesonide&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-04T02:48:46.917Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00659841", "title": "To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Seasonal", "Hay Fever" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 302, "start_date": "2003-12", "completion_date": "2005-02", "has_results": false, "last_update_posted_date": "2016-12-02", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 6, "location_summary": "Austin, Texas • Kerrville, Texas • New Braunfels, Texas + 1 more", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Kerrville", "state": "Texas" }, { "city": "New Braunfels", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00659841" }, { "nct_id": "NCT00163488", "title": "Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis", "Allergic Rhinitis", "Hay Fever" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 106, "start_date": "2005-01", "completion_date": "2005-08", "has_results": false, "last_update_posted_date": "2016-12-05", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 1, "location_summary": "Long Beach, California", "locations": [ { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00163488" }, { "nct_id": "NCT01033825", "title": "Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide HFA Nasal Aerosol 320 mcg", "type": "DRUG" }, { "name": "Ciclesonide HFA Nasal Aerosol 160 mcg", "type": "DRUG" }, { "name": "HFA Nasal Aerosol placebo", "type": "DRUG" }, { "name": "Ciclesonide Aqueous Nasal Spray 200 mcg", "type": "DRUG" }, { "name": "AQ Nasal Spray Placebo", "type": "DRUG" }, { "name": "Placebo plus Dexamethasone HFA", "type": "DRUG" }, { "name": "Placebo AQ plus Dexamethasone 6 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 310, "start_date": "2010-01", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2012-07-19", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 6, "location_summary": "Stockbridge, Georgia • North Dartmouth, Massachusetts • Minneappolis, Minnesota + 3 more", "locations": [ { "city": "Stockbridge", "state": "Georgia" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneappolis", "state": "Minnesota" }, { "city": "Skillman", "state": "New Jersey" }, { "city": "New Braunfels", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01033825" }, { "nct_id": "NCT00174720", "title": "Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Ciclesonide (XRP1526)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 708, "start_date": "2005-09", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2009-04-08", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00174720" }, { "nct_id": "NCT00807053", "title": "Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rhinitis, Allergic, Seasonal" ], "interventions": [ { "name": "Ciclesonide HFA", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 480, "start_date": "2007-04", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2016-12-05", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 31, "location_summary": "Mission Viejo, California • Orange, California • San Diego, California + 28 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00807053" }, { "nct_id": "NCT06272370", "title": "Individualizing Treatment for Asthma in Primary Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma", "Bronchial Diseases", "Respiratory Tract Infections", "Lung Diseases, Obstructive", "Lung Diseases", "Respiratory Hypersensitivity", "Immune System Diseases" ], "interventions": [ { "name": "Asthma Symptom Monitoring online tools", "type": "OTHER" }, { "name": "Inhaled Steroids", "type": "DRUG" }, { "name": "Azithromycin Pill", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "DARTNet Institute", "sponsor_class": "OTHER_GOV", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 103, "start_date": "2024-02-01", "completion_date": "2024-12-31", "has_results": true, "last_update_posted_date": "2025-04-20", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06272370" }, { "nct_id": "NCT04377711", "title": "A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Covis Pharma S.à.r.l.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "12 Years to 100 Years" }, "enrollment_count": 400, "start_date": "2020-06-08", "completion_date": "2021-01-05", "has_results": true, "last_update_posted_date": "2023-02-09", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04377711" }, { "nct_id": "NCT01654536", "title": "A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide nasal aerosol", "type": "DRUG" }, { "name": "ciclesonide nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 737, "start_date": "2012-09", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2014-07-24", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 31, "location_summary": "Mission Viejo, California • Orange, California • San Diego, California + 26 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01654536" }, { "nct_id": "NCT01010971", "title": "Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide HFA 160 μg", "type": "DRUG" }, { "name": "Ciclesonide HFA 80 μg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 671, "start_date": "2009-12", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2012-06-13", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 7, "location_summary": "Austin, Texas • New Braunfels, Texas • San Antonio, Texas", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "New Braunfels", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01010971" }, { "nct_id": "NCT00659048", "title": "Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 106, "start_date": "2004-12", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2016-12-01", "last_synced_at": "2026-09-04T02:48:46.917Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00659048" } ] }